Holen Sie sich die Stockscreener-App
325.07
4.29%
13.38
Handel nachbörslich:
325.07
Schlusskurs vom Vortag:
$311.69
Offen:
$321.01
24-Stunden-Volumen:
1.59M
Relative Volume:
1.09
Marktkapitalisierung:
$46.86B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-198.07
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+2.88%
1M Leistung:
+19.78%
6M Leistung:
+50.24%
1J Leistung:
+103.02%
1-Tages-Spanne:
$313.46
$325.83
1-Wochen-Bereich:
$305.00
$325.83
52-Wochen-Spanne:
$156.71
$326.03
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
325.07 | 44.93B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
613.54 | 217.80B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
211.50 | 140.30B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.20 | 43.59B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
155.41 | 41.92B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
BlackRock Inc. Buys Shares of 10,914,608 Natera, Inc. $NTRA - MarketBeat
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today - benzinga.com
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks - Yahoo Finance
Meeder Asset Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Pallas Capital Advisors LLC Buys Shares of 9,853 Natera, Inc. $NTRA - MarketBeat
How Investors May Respond To Natera (NTRA) Deepening Its MRD Role In Immunotherapy And Cancer Care - simplywall.st
K.J. Harrison & Partners Inc Buys Shares of 18,850 Natera, Inc. $NTRA - MarketBeat
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $330 - Moomoo
Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer - Yahoo Finance
NTRA Looks 42.4% Overvalued on GF Value™ - GuruFocus
Weekly Recap: FIND-CRC progress and analyst price target increases - TradingView
Natera, Inc. (NTRA) Stock Analysis: Navigating the Diagnostics Leader’s 6.68% Potential Upside - DirectorsTalk Interviews
Abbot Financial Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Empowered Funds LLC Sells 9,708 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Jonathan Sheena sells $2.89m in stock By Investing.com - Investing.com Canada
Natera executive chairman Matthew Rabinowitz sells $641,800 stock By Investing.com - Investing.com Australia
Natera executive chairman Matthew Rabinowitz sells $641,800 stock - Investing.com
Net debt of Natera, Inc. – HAM:45E - TradingView
Natera director Jonathan Sheena sells $2.89m in stock - Investing.com
Natera (NTRA) Stock May Be 49% Undervalued As Guidance Rises - Yahoo Finance
Leeward Financial Partners LLC Invests $5.31 Million in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Lands Kupando Trial Deal, Is The Upside Already Priced In? - simplywall.st
GSA Capital Partners LLP Invests $3.08 Million in Natera, Inc. $NTRA - MarketBeat
7,701 Shares in Natera, Inc. $NTRA Bought by Focus Partners Advisor Solutions LLC - MarketBeat
Natera (NTRA) Lands New Trial Collaboration But Is The Valuation Already Priced In - Yahoo Finance
Natera co-founder, Director Sheena Jonathan sells 6,000 shares worth $1.95 million - Bitget
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference - MarketBeat
Foresite Capital Management VI LLC's Natera Inc(NTRA) Holding History - GuruFocus
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call - Yahoo Finance
Natera director Jonathan Sheena sells $1.95m in common stock By Investing.com - Investing.com Australia
Natera director Jonathan Sheena sells $1.95m in common stock - Investing.com
T. Rowe Price Associates (NTRA) discloses 9.0M-share Natera stake in updated 13G - Stock Titan
Natera (NTRA) Stock Looks Reasonable On Cash Flow But Rich On Sales - simplywall.st
Natera (NASDAQ:NTRA) Stock Rating Upgraded by Zacks Research - MarketBeat
NTRA Maintained by Citigroup -- Price Target Raised to $365 - GuruFocus
Citigroup Raises Natera (NASDAQ:NTRA) Price Target to $365.00 - MarketBeat
NATERA, INC. : GUGGENHEIM RAISES TARGET PRICE TO $360 FROM $290 - webull.com
Natera at Canaccord Genuity conference: Signatera drives growth By Investing.com - Investing.com Nigeria
Natera at Canaccord Genuity conference: Signatera drives growth - Investing.com
NTRA Maintained by Piper Sandler -- Price Target Raised to $363. - GuruFocus
NTRA Maintained by Stephens & Co. -- Price Target Raised to $350 - GuruFocus
Natera (NASDAQ:NTRA) Price Target Raised to $363.50 at Piper Sandler - MarketBeat
Natera and Kupando Therapeutics Partner for Phase I Trial of KUP-101 in Advanced Skin Cancers - The Dermatology Digest
NTRA Maintained by Guggenheim -- Price Target Raised to $360 - GuruFocus
Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers - TradingView
Guggenheim Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $360 - Moomoo
Natera partners with Kupando for phase 1 cancer trial in Germany - Investing.com Australia
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers - Yahoo Finance
E. Ohman J or Asset Management AB Sells 24,163 Shares of Natera, Inc. $NTRA - MarketBeat
NATERA, INC. : PIPER SANDLER RAISES TARGET PRICE TO $363.5 FROM $249 - Bitget
Technical Reactions to NTRA Trends in Macro Strategies - Stock Traders Daily
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):